Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve, Inc. is a Canada-based healthcare technology company. The Company has two business units: Medivolve Pharmacy Division (MPD) and Collection Sites Diagnostics (CSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine, and psychiatry to patients in Southern California. CSD’s software platform, Electronic Health Records app (EHR), is focused on supporting clinical staff, is a series of assets and functionalities that enhance the customer experience and provide an end-to-end lab solution. The Company, through its subsidiaries, Medivolve Pharmacy Inc., and Kedy Ying Jao D.O., a medical corporation, operate a distributed network of two retail patient-care locations in California, United States. The Company has served hundreds of thousands of patients across the United States and facilitated more than 1,533,000 clinical tests.


OTCPK:MEDVF - Post by User

Comment by rankininleton Feb 13, 2021 9:15am
99 Views
Post# 32561231

RE:Yes I agree, if you have a Question ask the management

RE:Yes I agree, if you have a Question ask the managementWe need to keep in mind, collection sites are still growing. Collection sites generated USD 7.1 million in January with 32 testing sites. February started with 62 collection sites (almost double compare to January) and should end with 107 collection sites. They also added another 15 as comings soon in California. So that makes it 126 collection sites including coming soon. This can make March 4xcollection sites compare to January.

4 x 7.1 million = 28.4 million sales estimate for month of March,  Same or more for April.  Means year to date calendar 2021 sales  hit 109 million in May ( 7 + 14 + 28 + 30 + 30  = 109).  Thats capping monthly sales at 30 million or 1 million per day.  That excludes any revenue from newly added products or services. That does not include the positive impact of adding new locations or the potential sales decline as vaccinations kick-in.

Being conservative, using the conservative daily sales of 1 million for the remaining 7 months we could estimate June to Dec sales as 30 mil x 7 mo is 210mm. 

Calendar 2021 sales 109mm + 210mm = 319mm sales in US$ as a very quick back of napkin tabulation.  At some point, the stock market will almost certainly see MEDV as under priced.

<< Previous
Bullboard Posts
Next >>